Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Cardiovascular Ultrasound Systems
... at a CAGR of 5.1% over the analysis period 2024-2030. Stress Echocardiogram Test, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.0 Billion by the end ... Read More
-
Cancer Supportive Care
... at a CAGR of 2.2% over the analysis period 2024-2030. Opioids, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$11.1 Billion by the end of the ... Read More
-
Penile Implants
... CAGR of 4.3% over the analysis period 2024-2030. Inflatable Implant, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$557.9 Million by the end of the analysis ... Read More
-
Peptic Ulcer Drugs
... at a CAGR of 2.2% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Perfusion Systems
... CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the ... Read More
-
Vaginal Moisturizers
... CAGR of 4.2% over the analysis period 2024-2030. Retail Stores End-Use, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$155.2 Million by the end of the ... Read More
-
Vaginal Odor Control Product
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Intimate Wash, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.2 Billion by the ... Read More
-
Psychiatric and Substance Abuse Hospitals
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Alcoholism Rehabilitation Hospitals, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$13.5 ... Read More
-
NDDS in Cancer Therapy
... 2030, growing at a CAGR of 20.7% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.6% CAGR and reach US$67.8 Billion by the end ... Read More
-
Allergy Immunotherapy
... CAGR of 9.4% over the analysis period 2024-2030. Subcutaneous Immunotherapy (SCIT), one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$3.4 Billion by the end of the ... Read More
-
Basal Cell Carcinoma Treatment
... 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Surgery Treatment, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$7.6 Billion by the ... Read More
-
Extracorporeal CO2 Removal Devices
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$89.9 Million by ... Read More
-
Ligament Stabilizers
... CAGR of 4.6% over the analysis period 2024-2030. Grade 1 Injury, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
Breast Cancer Therapeutics
... at a CAGR of 12.3% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$74.9 Billion by the end of ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Urinary Tract Infection Treatment
... 2030, growing at a CAGR of 2.5% over the analysis period 2024-2030. Quinolones, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$5.2 Billion by the end ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More
-
Foot and Ankle Braces
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. The U.S. Market is Estimated at US$256.8 Million While China is Forecast to Grow at 10.6% CAGR The Foot and Ankle Braces market ... Read More
-
Wrist and Hand Braces
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$90.5 Million While China is Forecast to Grow at 9.6% CAGR The Wrist and Hand Braces market ... Read More
-
Soft Tissue Allografts
... at a CAGR of 4.9% over the analysis period 2024-2030. Orthopedic Application, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Heart Failure Drugs
... at a CAGR of 12.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 16.3% CAGR The Heart Failure Drugs market in the U.S. ... Read More
-
Dermatology Devices
... CAGR of 9.5% over the analysis period 2024-2030. Treatment Devices, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$20.5 Billion by the end of the analysis ... Read More
-
Emergency Contraceptive Pills
... at a CAGR of 2.4% over the analysis period 2024-2030. Combination Pills, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$484.2 Million by the end of ... Read More
-
Gastrointestinal Therapeutics
... CAGR of 5.1% over the analysis period 2024-2030. Crohn`s Disease End-Use, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion by the end of the ... Read More
Research Assistance
